Risk for Fractures with Centrally Acting Muscle Relaxants: An Analysis of a National Medicare Advantage Claims Database

Abstract

Spanish

French

Background:

In older adults, both muscle relaxants and benzodiazepines are associated with sedation and cognitive impairment. Although benzodiazepines have been linked to falls and fracture injuries, no studies have examined the risk of fracture associated with muscle relaxants.

Objective:

To determine whether muscle relaxants identified in the Beers criteria are associated with an increased risk of fracture injuries and to compare this risk to that with benzodiazepine use.

Methods:

We conducted a case-control study using both medical and pharmacy claims data from 1.5 million enrollees in the Medicare Advantage plans of a large health maintenance organization. We matched 8164 cases of fractures with 8164 controls based on age, sex, health plan, and comorbidities. We measured the use of muscle retaxants, short-acting benzodiazepines, and long-acting benzodiazepines. Adjusted odds ratios were estimated using conditional logistic regression,

Results:

After adjusting demographic and clinical covariates, muscle relaxants, long-acting benzodiazepines, and short-acting benzodiazepines were associated with a high risk of fracture injuries, with odds ratios of 1.40 (95% CI 1.15 to 1.72; p < 0.001), 1.9 (95% CI 1.49 to 2.43: p < 0.001), and 1.33 (95% CI 1.15 to 1.55: p < 0.001), respectively.

Conclusions:

An elevated risk of fracture injuries was noted among older adults using muscle relaxants. Our findings provide evidence of an association between the risk of fractures and the use of centrally acting muscle relaxants in older adults. This association supports current recommendations advising extreme caution in prescribing muscle relaxants to older adults.

Keywords

benzodiazepines falls muscle relaxants

Get full access to this article

View all access options for this article.

References

See

, Ginzburg

. Choosing a skeletal muscle relaxant. Am Fam Physician 2008; 78:365–70.

Fantl

, Newman

, Colling

. Managing acute and chronic urinary incontinence. Clinical practice guideline. Quick reference guide for clinicians, no. 2, 1996 update. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Pub. No. 96–0686, January 1996.

Thüroff

, Abrams

, Anersson

. Guidelines on urinary incontinence. European Association of Urology, 2006. www.uroweb.org/fileadmm/user_upload/Guidelines/16%20Urinary%20Incontinence.pdf (accessed 2009 Sept 30).

Tulder

, Touray

, Furlan

. Muscle relaxants for non-specific low–back pain. Cochrane Database Syst Rev 2003; (4):CD004252. DOI 10.1002/14651858.CD004252

Chou

, Huffman

. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007; 147:505–14.

Kay

, About-Donia

, Messer

. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005: 53:2195–201.

Scheife

, Takeda

. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther 2005; 27:144–53.

Kamel

, Gammack

. Insomnia in the elderly: cause, approach, and treatment. Am J Med 2006; 119:463–9.

Woolcott

, Richardson

, Wiens

. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169:1952–60.

10.

Hartikainen

, Lonnroos

, Louhivuori

. Medication as a risk factor for falls: critical systematic review. J Gerontol 2007; 62:1172–81.

11.

Leipzig

, Cummings

, Tinetti

. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47:30–9.

12.

Cummings

, Nevitt

, Browner

. Risk factors for hip fractures in white women. N Engl J Med 1995; 332:767–73.

13.

Schneeweiss

, Wang

. Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information. J Am Geriatr Soc 2005; 53:948–54.

14.

Herings

, Strieker

, de Boer

. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995; 155:1801–7.

15.

Pierfítte

, Macouillard

, Thicipe

. Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 2001; 322:704–8.

16.

Wagner

, Zhang

, Soumerai

. Benzodiazepine use and hip fractures in the elderly. Arch Intern Med 2004; 164:1567–72.

17.

Avidan

, Fries

, James

. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005; 53:955–62.

18.

Wagner

, Ross-Degnan

, Gurwitz

. Effect of New York state regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med 2007; 146:96–103.

19.

Ensrud

, Blackwell

, Mangione

. Central nervous system active medications and risk of fractures in older women. Arch Intern Med 2003; 163:949–57.

20.

Fick

, Cooper

, Wade

. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163:2716–24.

21.

Zhan

, Sangl

, Bierman

. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 2001; 286:2823–9.

22.

Shrank

, Polinski

, Avorn

. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc 2007; 55:S373–82.

23.

Winchell

, King

, Chavez-Eng

. Cyclobenzaprine pharmacokinetics, including the effects of age, gender, and hepatic insufficiency. J Clin Pharmacol 2002; 42:61–9.

24.

Beers

. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997; 157:1531–6.

25.

Bulat

, Castle

, Rutledge

, Quigley

. Clinical practice algorithms: medications management to reduce fall risk in the elderly—part 4, anticoagulants, anticonvulsants, anticholinergics/bladder relaxants, and antipsychotics. J Am Acad Nurse Pract 2008; 20:181–90.

26.

Dillon

, Paulose-Ram

, Hirsch

, Gu

. Skeletal muscle relaxant use in the United States. Spine 2004; 29:892–6.

27.

Wysowski

, Baum

, Ferguson

, Lundin

, Moh-Jee

, Hammerstrom

. Sedative hypotic drugs and the risk of hip fractures. J Clin Epidemiol 1996; 49:111–3.

28.

Sattin

. Falls among older persons: a public health perspective. Annu Rev Publ Health 1992; 13:489–508.

29.

Deyo

, Cherkin

, Ciol

. Adapting a clinical comorbidity index for use with ICD -9-CM administrative databases. J Clin Epidemiol 1992; 45:613–9.

30.

Food and Drug Administration. NDC codes, www.fda.gov/cder/ndc/database/default.htm (accessed 2009 Mar 18).

31.

Rochan

, Stukel

, Bronskill

. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007; 167:676–83.

32.

Rapoport

, Mamdani

, Shulman

, Herrmann

, Rochan

. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry 2005; 20:749–53.

33.

Rochan

, Normand

S-L

, Gomes

. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168:1090–6.

34.

Anderson

, Mobley

, Blank

. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. J Urol 1999; 161:1809–12.

35.

Versi

, Appell

, Mobley

. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. Obstet Gynecol 2000; 95:718–21.

36.

Coutinho

ESF

, Fletcher

, Bloch

, Rodrigues

. Risk factors for falls with severe fracture in elderly people living in a middle-income country: a case control study. BMC Geriatr 2008; 8:21. DOI 10.1186/1471–2318-8-21

37.

French

, Campbell

, Spehar

, Rubenstein

, Branch

, Cunningham

. National outpatient medication profiling: medications associated with outpatient fractures in community-dwelling elderly veterans. Br J Clin Pharmacol 2006; 63:238–44.

38.

Bramness

, Skurtveit

, M⊘rland

, Engeland

. The risk of traffic accidents after prescription of carisoprodol. Accid Anal Prev 2007; 39:1050–5.

39.

Hanlon

, Boudreau

, Roumani

. Number and dosage of central nervous system medications on recurrent falls in community elders: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2009; 64A:492–8.

40.

Lewiecki

. Managing osteoporosis: challenges and strategies. Cleve Clin J Med 2009; 76:457–66.

41.

Wilkins

, Birge

. Prevention of osteoporotic fractures in the elderly. Am J Med 2005; 118:1190–5.

42.

Foley

, Foster

, Meadows

, Baser

, Long

. Assessment of the clinical management of fragility fractures and implications for the new HEDIS osteoporosis measure. Med Care 2007; 45:902–6.

43.

Leipzig

, Cumming

, Tinetti

. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47:40–50.

44.

Lawlor

, Patel

, Ebrahim

. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003; 327:712–8.

45.

Chen

, Simpson

, March

. Fracture risk assessment in frail older people using clinical risk factors. Age Ageing 2008; 37:536–41.